title: Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity.
abstract: Logistical and ethical reasons make conducting clinical research in paediatric practice difficult, and therefore safe and efficacious advances are dependent on good preclinical research. For example, notable advances have been made in preclinical studies of pain processing that correlate well with patient data. Other areas of paediatric anaesthetic research remain in their infancy including mechanisms of anaesthesia and anaesthetic neuroprotection and neurotoxicity. Animal data have identified the potential 'double-edged' sword of administering anaesthetic agents in the young; although these agents can be neuroprotective in certain circumstances, they can be neurotoxic in others. The potential for this toxicity must be balanced against the importance of providing adequate anaesthesia for which there can be no compromise. We review the current state of preclinical research in paediatric anaesthesia and identify areas which require further exploration in order to provide the foundations for well-conducted clinical trials.
authors.affiliation: Department of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, London, UK. robert.sanders@ic.ac.uk
authors.forename: R D
authors.initials: RD
authors.lastname: Sanders
authors.forename: D
authors.initials: D
authors.lastname: Ma
authors.forename: P
authors.initials: P
authors.lastname: Brooks
authors.forename: M
authors.initials: M
authors.lastname: Maze
mesh_terms: D000698:Analgesia / Q000379:methods*; D000758:Anesthesia / Q000379:methods*; D000777:Anesthetics / Q000009:adverse effects; D000818:Animals; D035843:Biomedical Research / Q000379:methods; D002648:Child; D016292:Procedural Sedation / Q000379:methods*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use
chemical_list: D000777:Anesthetics; D018696:Neuroprotective Agents